132 related articles for article (PubMed ID: 12435206)
1. Management of small bowel adenocarcinoma.
Kummar S; Ciesielski TE; Fogarasi MC
Oncology (Williston Park); 2002 Oct; 16(10):1364-9; discussion 1370, 1372-3. PubMed ID: 12435206
[TBL] [Abstract][Full Text] [Related]
2. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.
Abrahams NA; Halverson A; Fazio VW; Rybicki LA; Goldblum JR
Dis Colon Rectum; 2002 Nov; 45(11):1496-502. PubMed ID: 12432298
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and Treatment Strategies for Small Bowel Adenocarcinoma in Advanced-stage Cases.
Nakanoko T; Koga T; Taketani K; Hirayama Y; Yoshiya S; Minagawa R; Kai M; Kajiyama K; Maehara Y
Anticancer Res; 2015 Jul; 35(7):4135-8. PubMed ID: 26124367
[TBL] [Abstract][Full Text] [Related]
4. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine.
Overman MJ; Kopetz S; Lin E; Abbruzzese JL; Wolff RA
Acta Oncol; 2010 May; 49(4):474-9. PubMed ID: 20397775
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy in advanced small bowel adenocarcinoma.
Locher C; Malka D; Boige V; Lebray P; Elias D; Lasser P; Ducreux M
Oncology; 2005; 69(4):290-4. PubMed ID: 16282708
[TBL] [Abstract][Full Text] [Related]
6. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.
Fishman PN; Pond GR; Moore MJ; Oza A; Burkes RL; Siu LL; Feld R; Gallinger S; Greig P; Knox JJ
Am J Clin Oncol; 2006 Jun; 29(3):225-31. PubMed ID: 16755174
[TBL] [Abstract][Full Text] [Related]
7. Primary adenocarcinoma of the small intestine: presentation, prognostic factors and clinical outcome.
Hong SH; Koh YH; Rho SY; Byun JH; Oh ST; Im KW; Kim EK; Chang SK
Jpn J Clin Oncol; 2009 Jan; 39(1):54-61. PubMed ID: 18997182
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
[TBL] [Abstract][Full Text] [Related]
9. [Small bowel adenocarcinoma].
Zaanan A; Afchain P; Carrere N; Aparicio T
Gastroenterol Clin Biol; 2010; 34(6-7):371-9. PubMed ID: 20537487
[TBL] [Abstract][Full Text] [Related]
10. [Treatment and outcome in small bowel cancer].
Ogata Y; Yamaguchi K; Sasatomi T; Uchida S; Akagi Y; Shirouzu K
Gan To Kagaku Ryoho; 2010 Aug; 37(8):1454-7. PubMed ID: 20716869
[TBL] [Abstract][Full Text] [Related]
11. Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients.
Cao J; Zuo Y; Lv F; Chen Z; Li J
J Clin Gastroenterol; 2008 Feb; 42(2):167-73. PubMed ID: 18209587
[TBL] [Abstract][Full Text] [Related]
12. Evolving pharmacotherapeutic strategies for small bowel adenocarcinoma.
Trikudanathan G; Dasanu CA
Expert Opin Pharmacother; 2010 Jul; 11(10):1695-704. PubMed ID: 20446863
[TBL] [Abstract][Full Text] [Related]
13. Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives.
Zaaimi Y; Aparicio T; Laurent-Puig P; Taieb J; Zaanan A
Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):154-60. PubMed ID: 26547136
[TBL] [Abstract][Full Text] [Related]
14. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.
Dabaja BS; Suki D; Pro B; Bonnen M; Ajani J
Cancer; 2004 Aug; 101(3):518-26. PubMed ID: 15274064
[TBL] [Abstract][Full Text] [Related]
16. [A case report of primary adenocarcinoma of small intestine successfully treated with FOLFOX].
Sugae T; Yaguchi T; Kajikawa M; Nakayama S; Takase T; Inokawa Y; Tsushima Y; Watanabe T; Harada A
Gan To Kagaku Ryoho; 2008 Nov; 35(11):1969-71. PubMed ID: 19011354
[TBL] [Abstract][Full Text] [Related]
17. New aspects of prognostic factors in adenocarcinomas of the small bowel.
Brücher BL; Stein HJ; Roder JD; Busch R; Fink U; Werner M; Siewert JR
Hepatogastroenterology; 2001; 48(39):727-32. PubMed ID: 11462914
[TBL] [Abstract][Full Text] [Related]
18. What are the latest pharmacotherapy options for small bowel adenocarcinoma?
Ynson ML; Senatore F; Dasanu CA
Expert Opin Pharmacother; 2014 Apr; 15(6):745-8. PubMed ID: 24588646
[TBL] [Abstract][Full Text] [Related]
19. Small intestinal adenocarcinoma: rarely considered, often missed?
Neely D; Ong J; Patterson J; Kirkpatrick D; Skelly R
Postgrad Med J; 2013 Apr; 89(1050):197-201. PubMed ID: 23412393
[TBL] [Abstract][Full Text] [Related]
20. The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil.
Crawley C; Ross P; Norman A; Hill A; Cunningham D
Br J Cancer; 1998 Aug; 78(4):508-10. PubMed ID: 9716035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
